Search results
Results From The WOW.Com Content Network
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
This is a list of current and former companies based in the San Francisco Bay Area, broken down by type of business. Fortune 500 rankings are indicated in parentheses. As of 2020, 38 Fortune 500 companies had headquarters in the San Francisco Bay Area. [1]
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Aaron Sims Company; Abgent; Acadia Pharmaceuticals; Accelrys; Access Books; ACT Biotech Inc; Activision; Actuate Corporation; AdGreetz; Adobe Inc. Advanced Micro Devices
FUJIFILM Diosynth Biotechnologies, abbreviated and often referred to as FDB, is a biopharmaceutical contract manufacturing organization that develops manufacturing processes and manufactures active ingredients and provides fill and finish services for pharmaceutical companies. [1]
Crown Bioscience is a company that offers a range of preclinical and translational drug research and development platforms and services. These include in vivo, in vitro, ex vivo patient derived xenograft (PDX), cell line derived xenograft (CDX), organoids and 3D models, as well as oncology databases, biomarker, bioanalysis and bioinformatics services.
Atypical of a private company, the initial focus will be on basic research without immediate prospects of a commercially viable product. [ 2 ] In January 2022, the company's president, Hans Bishop , argued that Altos Labs was working on increasing the " healthspan " of humans and that longevity extension would only be "an accidental consequence".